Press Releases
| [+] |
March 02, 2004 Ambrx Adds to Senior Management Team with the Appointment of John Wallen as Vice President, Intellectual Property SAN DIEGO, CA – March 02, 2004 – Ambrx, Inc., a research and development company transforming protein therapeutics through the incorporation of new amino acid building blocks, announced today that John W. Wallen, III, Ph.D., J.D. has joined the company as Vice President, Intellectual Property. Dr. Walle… Read More |
Articles
- April 1, 2005
Unnatural Amino Acid Could Prove Boon for Protein Therapeutics
Science Magazine - March 14, 2005
Giving Biotechnology A Chemical Push
Chemical & Engineering News - March 14, 2005
Watching Peptide Drugs Grow Up
Chemical & Engineering News - January 12, 2004
The Code Breakers
Bio-IT World - October 6, 2003
Executive Profile - RICHARD D. DIMARCHI
SD Business Journal (paid access) - September 29, 2003
Ambrx Inc. Lands $12.5M in First-Round Funding
SD Business Journal (paid access) - September 23, 2003
First-Round Financing of $12.5M Puts Ambrx On Development Path
BioWorld Today - September 22, 2003
Schultz seeks another success with Ambrx
The Daily Deal
